Are We Missing Treatment Standards for Thromboprophylaxis of the Obese and Super-Obese Patient Population? A Prospective Systematic Cohort Study.
Christine StierAnn-Cathrin KoschkerRaphael StierAlexander SosnierzSonja ChiappettaPublished in: Obesity surgery (2021)
Measurement of the aFXa level helps to define the real prophylactic thromboprophylaxis status in patients with obesity, especially in those with a weight above 150 kg. In patients at risk, the measurement of aFXa should be considered in routine clinical practice.
Keyphrases
- weight loss
- clinical practice
- metabolic syndrome
- end stage renal disease
- type diabetes
- adipose tissue
- venous thromboembolism
- bariatric surgery
- ejection fraction
- chronic kidney disease
- newly diagnosed
- insulin resistance
- weight gain
- physical activity
- body mass index
- case report
- prognostic factors
- peritoneal dialysis
- direct oral anticoagulants
- skeletal muscle
- combination therapy
- atrial fibrillation